← FDA DRUG APPROVALS

FDA ANDA · ANDA088791

VASOCIDIN

Sponsor: NOVARTIS

APPLICATION
ANDA088791
TYPE
ANDA
ORIGINAL APPROVAL
1984-10-05
LATEST ACTION
1997-12-05
ROUTE
OPHTHALMIC
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

VASOCIDINDiscontinued
PREDNISOLONE ACETATE 0.5%, SULFACETAMIDE SODIUM 10% · OINTMENT · OPHTHALMIC

Approval history

1997-12-05Manufacturing (CMC) · Supplement 11AP
1996-08-13Manufacturing (CMC) · Supplement 13AP
1996-07-03Manufacturing (CMC) · Supplement 12AP
1995-12-15Manufacturing (CMC) · Supplement 10AP
1994-05-06Labeling · Supplement 9AP
1993-01-29Labeling · Supplement 8AP
1991-12-09Labeling · Supplement 6AP
1991-02-15Manufacturing (CMC) · Supplement 7AP
1985-09-17Manufacturing (CMC) · Supplement 4AP
1984-10-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →